Loading…
India Gelatine & Chemicals (BSE 531253)₹357.70+1.59%Specialty Chemicals
In the Mar 2026 quarter (standalone), India Gelatine & Chemicals reported sales of ₹38.99 Cr, down 26.7% from Mar 2025, and net profit of ₹4.50 Cr, down 21.5% year on year. For the year to Mar 2026, sales were ₹170 Cr and net profit ₹25.09 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 58.05 | 48.74 | 47.84 | 51.24 | 50.12 | 42.74 | 52.59 | 53.17 | 39.13 | 46.91 | 44.84 | 38.99 |
| Expenses | 45.49 | 41.04 | 40.16 | 43.62 | 44.11 | 38.90 | 48.32 | 45.52 | 31.12 | 38.14 | 37.04 | 33.86 |
| Operating Profit | 12.41 | 7.59 | 7.59 | 7.46 | 5.86 | 3.71 | 4.12 | 7.52 | 7.91 | 8.64 | 7.69 | 5.01 |
| OPM % | 21.4% | 15.5% | 15.8% | 14.5% | 11.7% | 8.6% | 7.8% | 14.1% | 20.2% | 18.4% | 17.2% | 12.8% |
| Other Income | 2.15 | 1.92 | 2.55 | 1.66 | 2.33 | 1.88 | 1.69 | 1.81 | 2.21 | 1.83 | 2.03 | 2.35 |
| Interest | 0.11 | 0.19 | 0.12 | 0.27 | 0.16 | 0.10 | 0.11 | 0.27 | 0.10 | 0.10 | 0.08 | 0.16 |
| Depreciation | 1.18 | 1.20 | 1.19 | 1.73 | 1.35 | 1.37 | 1.43 | 1.39 | 1.16 | 1.17 | 1.07 | 1.15 |
| Profit before tax | 13.26 | 8.11 | 8.82 | 7.11 | 6.67 | 4.11 | 4.26 | 7.66 | 8.85 | 9.21 | 8.56 | 6.04 |
| Tax % | 24.3% | 31.8% | 11.4% | 29.3% | 24.3% | 24.6% | 16.0% | 25.4% | 19.8% | 30.0% | 16.9% | 25.7% |
| Net Profit | 10.07 | 5.54 | 7.84 | 5.04 | 5.06 | 3.10 | 3.57 | 5.73 | 7.10 | 6.46 | 7.12 | 4.50 |
| EPS (Rs) | 14.17 | 7.79 | 11.02 | 7.09 | 7.12 | 4.37 | 5.01 | 8.06 | 9.99 | 9.09 | 10.02 | 6.33 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 92.99 | 73.99 | 98.02 | 112 | 132 | 144 | 160 | 205 | 206 | 199 | 170 | 170 |
| Expenses | 88.74 | 73.79 | 95.71 | 107 | 124 | 135 | 152 | 172 | 170 | 176 | 140 | 140 |
| Operating Profit | 4.01 | 1.01 | 2.01 | 5.01 | 7.01 | 9.01 | 8.01 | 33.04 | 35.02 | 21.01 | 29.01 | 29.25 |
| OPM % | 4.8% | 0.8% | 1.6% | 4.9% | 6.0% | 6.0% | 4.8% | 16.0% | 17.0% | 11.0% | 17.0% | 17.2% |
| Other Income | 5.01 | 6.01 | 4.01 | 4.01 | 2.99 | 4.01 | 4.01 | 3.01 | 8.01 | 8.01 | 8.01 | 8.42 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.00 | 0.44 |
| Depreciation | 5.01 | 3.01 | 3.01 | 3.01 | 3.01 | 4.01 | 4.01 | 4.01 | 5.01 | 6.02 | 5.01 | 4.55 |
| Profit before tax | 5.01 | 3.01 | 3.01 | 6.01 | 6.01 | 9.01 | 7.01 | 32.04 | 37.02 | 23.02 | 33.03 | 32.66 |
| Tax % | 23.0% | −5.0% | 16.0% | −1.0% | 15.9% | 23.0% | 24.0% | 25.0% | 24.0% | 23.0% | 23.0% | — |
| Exceptional items | 2.01 | 1.01 | 0.00 | 0.00 | −1.01 | 1.01 | 1.01 | 1.01 | 3.01 | 4.01 | 4.01 | — |
| Net Profit | 4.01 | 3.01 | 2.01 | 6.02 | 5.02 | 7.03 | 6.02 | 24.07 | 28.10 | 17.06 | 25.09 | 25.18 |
| EPS (Rs) | 3.90 | 3.38 | 3.20 | 8.10 | 7.57 | 10.01 | 7.92 | 33.73 | 40.05 | 24.54 | 35.43 | 35.43 |
| Dividend payout % | 23.1% | 27.0% | 63.0% | 43.1% | 20.0% | 25.0% | 32.0% | 15.0% | 27.0% | 20.1% | 17.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.96 | 8.96 | 8.96 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 |
| Reserves | 109 | 112 | 115 | 91.78 | 94.80 | 96.77 | 103 | 108 | 129 | 147 | 164 | 185 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.96 | 7.97 | 5.98 | 3.98 |
| Other Liabilities | 34.83 | 34.83 | 16.92 | 16.92 | 13.93 | 18.91 | 16.92 | 21.89 | 32.84 | 21.89 | 16.91 | 18.91 |
| Total Liabilities | 154 | 156 | 141 | 115 | 116 | 124 | 127 | 136 | 179 | 183 | 194 | 216 |
| Fixed Assets | 46.90 | 44.88 | 43.91 | 41.91 | 41.92 | 42.87 | 39.90 | 40.89 | 59.83 | 68.87 | 67.81 | 60.88 |
| CWIP | 0.99 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 3.98 | 1.99 | 0.99 | 19.92 |
| Investments | 12.95 | 6.98 | 35.85 | 29.90 | 29.90 | 27.92 | 33.88 | 32.90 | 42.83 | 43.87 | 54.85 | 65.80 |
| Other Assets | 92.76 | 104 | 59.76 | 42.86 | 43.88 | 52.86 | 51.81 | 61.79 | 72.76 | 69.72 | 70.76 | 69.73 |
| Inventories | 28.91 | 23.98 | 30.79 | 26.19 | 24.63 | 28.84 | 27.74 | 29.36 | 41.13 | 43.56 | 36.16 | 35.44 |
| Trade receivables | 3.92 | 6.11 | 4.54 | 4.50 | 5.28 | 6.43 | 9.35 | 11.55 | 13.83 | 12.67 | 12.15 | 9.88 |
| Cash & equivalents | 30.59 | 40.50 | 8.61 | 3.33 | 5.57 | 7.16 | 6.04 | 6.17 | 9.11 | 5.82 | 6.08 | 10.51 |
| Total Assets | 154 | 156 | 141 | 115 | 116 | 124 | 127 | 136 | 179 | 183 | 194 | 216 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 16.96 | 3.99 | −3.99 | 14.95 | 4.98 | 6.98 | 5.98 | 8.97 | 17.94 | 17.93 | 20.93 | 27.91 |
| Cash from investing activity | 3.01 | 8.03 | −27.08 | −19.06 | −1.01 | −3.01 | −6.02 | −8.04 | −21.07 | −8.03 | −17.06 | −23.08 |
| Cash from financing activity | −1.99 | −1.99 | −0.99 | −0.99 | −1.99 | −2.99 | −0.99 | −1.99 | 6.98 | −12.97 | −3.98 | −6.98 |
| Net cash flow | 18.05 | 10.03 | −32.07 | −5.01 | 2.01 | 1.01 | −1.01 | −1.01 | 3.01 | −3.01 | 0.00 | −2.01 |
| Capex | 4.61 | 3.27 | 3.10 | 0.60 | 3.08 | 5.51 | 1.79 | 5.44 | 24.35 | 15.35 | 12.20 | 15.19 |
| Free cash flow | 16.96 | 0.99 | −6.99 | 13.98 | 1.99 | 1.99 | 4.99 | 3.99 | −5.99 | 4.99 | 8.98 | 19.97 |
| CFO / OP % | 320.0% | 136.0% | −675.0% | 971.0% | 105.0% | 136.0% | 81.0% | 146.1% | 70.1% | 79.0% | 120.1% | 125.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 12 | 24 | 22 | 17 | 17 | 18 | 24 | 26 | 25 | 22 | 22 | 21 |
| Inventory days | 198 | 187 | 365 | 209 | 180 | 178 | 129 | 130 | 176 | 182 | 136 | 182 |
| Days payable | 20 | 23 | 55 | 49 | 24 | 53 | 26 | 37 | 61 | 36 | 20 | 21 |
| Cash conversion cycle | 190 | 188 | 332 | 177 | 174 | 143 | 126 | 119 | 139 | 168 | 138 | 182 |
| Working capital days | 111 | 139 | 206 | 112 | 102 | 90 | 95 | 95 | 66 | 77 | 78 | 82 |
| ROCE % | 3.0% | 2.0% | 1.0% | 2.0% | 6.0% | 7.0% | 7.0% | 6.0% | 24.0% | 22.0% | 12.0% | 16.0% |
For the Mar 2026 quarter, India Gelatine & Chemicals reported sales of ₹38.99 Cr, down 26.7% year on year and net profit of ₹4.50 Cr, down 21.5% year on year. The operating margin was 12.8%.
India Gelatine & Chemicals' sales for the year to Mar 2026 were ₹170 Cr; over the last twelve months they were ₹170 Cr.
Net profit for the year to Mar 2026 was ₹25.09 Cr, and ₹25.18 Cr over the last twelve months. Earnings per share over the same trailing period were ₹35.43.
India Gelatine & Chemicals reported borrowings of ₹3.98 Cr at Mar 2026, against cash and equivalents of ₹10.51 Cr.
Cash from operations was ₹27.91 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹19.97 Cr.